What are the Challenges in Developing Liposomal Doxorubicin?
Despite its benefits, the development of liposomal doxorubicin faces several challenges:
Stability: Ensuring the stability of liposomes during storage and after administration is critical. Manufacturing: Scalable and reproducible manufacturing processes are necessary to produce consistent and high-quality liposomal formulations. Cost: The production and regulatory approval of liposomal drugs are often more expensive than conventional formulations.
